- Supported exchanges /
- PINK /
- MCET.PINK
Multicell Techs Inc (MCET PINK) stock market data APIs
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Multicell Techs Inc Financial Data Overview
| 0 | |
| 0 | |
| - | |
| 0 | |
| 0 | |
| 0-0.0001 | |
| 1 000 K | |
| 0 | |
| 5 001 M | |
| 805 K | |
| 0 | |
| -37.216 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Multicell Techs Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 805 K
- EBITDA 0
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Multicell Techs Inc Earnings via APIs
- Latest Release 2024-04-17
- EPS/Forecast 0
Get Multicell Techs Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
